
Present challenges in the global prevention of blindness
Author(s) -
Thylefors B
Publication year - 1992
Publication title -
australian and new zealand journal of ophthalmology
Language(s) - English
Resource type - Journals
eISSN - 1440-1606
pISSN - 0814-9763
DOI - 10.1111/j.1442-9071.1992.tb00717.x
Subject(s) - trachoma , onchocerciasis , xerophthalmia , medicine , developing country , vitamin a deficiency , intervention (counseling) , blindness , optometry , disease , intensive care medicine , pediatrics , economic growth , nursing , vitamin , retinol , pathology , economics
Cataract is responsible for 50% of world blindness, with at present an estimated backlog of 13.5 million cases in need of surgery. Low‐cost cataract surgery must be made more available in developing countries, making use of alternative approaches for outpatient surgery and optimal management of available resources. Trachoma control needs to be targeted at the worst affected areas in endemic countries, with more emphasis on behavioural, educational and community aspects of the disease. Vitamin A deficiency and xerophthalmia control are becoming matters of maternal and child health care, with early intervention during infancy in view of the mortality issue. There are good prospects for the prevention of blindness from onchocerciasis, through the availability of ivermectin, but large‐scale distribution schemes are still needed in most of the African countries concerned. The early detection and management of open‐angle glaucoma still poses a major problem in developing countries, and further development of appropriate technology is needed in this field. Another area where more efforts are needed is ocular trauma, which is commonly the cause of unilateral loss of vision. General preventive measures must be enforced and better training provided to health personnel to deal competently with such cases, in order to prevent late complications. Diabetes, finally, is on the increase in many developing countries, giving rise to problems in dealing effectively with the ensuing retinopathy. Given the general constraints of resources and technology, more emphasis must be placed on general measures for optimal disease regulation and surveillance. Major efforts for the mobilisation of needed support for blindness prevention must be undertaken rapidly, in order to allow for proper eye care services in the developing countries and to counter a further increase in the number of the world's blind.